Identification and validation of a novel five-gene signature in high-risk MYCN-not-amplified neuroblastoma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Identification and validation of a novel five-gene signature in high-risk MYCN-not-amplified neuroblastoma ; volume:15 ; number:1 ; day:18 ; month:9 ; year:2024 ; pages:1-12 ; date:12.2024
Discover oncology ; 15, Heft 1 (18.9.2024), 1-12, 12.2024
- Urheber
-
Wang, Jin-Xia
Zhang, Hong-Yang
Yan, Zi-Jun
Cao, Zi-Yang
Shao, Jing-Bo
Zou, Lin
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s12672-024-01318-0
- URN
-
urn:nbn:de:101:1-2412012112438.867656312726
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:31 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wang, Jin-Xia
- Zhang, Hong-Yang
- Yan, Zi-Jun
- Cao, Zi-Yang
- Shao, Jing-Bo
- Zou, Lin
- SpringerLink (Online service)
Ähnliche Objekte (12)
SMAD9-MYCN positive feedback loop represents a unique dependency for MYCN-amplified neuroblastoma
Aurora-A prevents transcription-replication conflicts in MYCN-amplified neuroblastoma
MTHFD1 regulates the NADPH redox homeostasis in MYCN-amplified neuroblastoma
Genomic profile of MYCN non-amplified neuroblastoma and potential for immunotherapeutic strategies in neuroblastoma
Inhibitors of ribosome biogenesis repress the growth of MYCN-amplified neuroblastoma
LRP8‐mediated selenocysteine uptake is a targetable vulnerability in MYCN‐amplified neuroblastoma
Impact of extracellular matrix stiffness on genomic heterogeneity in MYCN-amplified neuroblastoma cell line
Age related gene DST represents an independent prognostic factor for MYCN non-amplified neuroblastoma
The long non-coding RNA MYCNOS-01 regulates MYCN protein levels and affects growth of MYCN-amplified rhabdomyosarcoma and neuroblastoma cells
Transcription factor activating protein 4 is synthetically lethal and a master regulator of MYCN-amplified neuroblastoma
Inhibition of autophagy potentiates the efficacy of Gli inhibitor GANT-61 in MYCN-amplified neuroblastoma cells
Understanding and Exploiting MYCN Addiction in High-Risk Neuroblastoma Using the Example of CDK13
SMAD9-MYCN positive feedback loop represents a unique dependency for MYCN-amplified neuroblastoma
Aurora-A prevents transcription-replication conflicts in MYCN-amplified neuroblastoma
MTHFD1 regulates the NADPH redox homeostasis in MYCN-amplified neuroblastoma
Genomic profile of MYCN non-amplified neuroblastoma and potential for immunotherapeutic strategies in neuroblastoma
Inhibitors of ribosome biogenesis repress the growth of MYCN-amplified neuroblastoma
LRP8‐mediated selenocysteine uptake is a targetable vulnerability in MYCN‐amplified neuroblastoma
Impact of extracellular matrix stiffness on genomic heterogeneity in MYCN-amplified neuroblastoma cell line
Age related gene DST represents an independent prognostic factor for MYCN non-amplified neuroblastoma
The long non-coding RNA MYCNOS-01 regulates MYCN protein levels and affects growth of MYCN-amplified rhabdomyosarcoma and neuroblastoma cells
Transcription factor activating protein 4 is synthetically lethal and a master regulator of MYCN-amplified neuroblastoma
Inhibition of autophagy potentiates the efficacy of Gli inhibitor GANT-61 in MYCN-amplified neuroblastoma cells
Understanding and Exploiting MYCN Addiction in High-Risk Neuroblastoma Using the Example of CDK13
SMAD9-MYCN positive feedback loop represents a unique dependency for MYCN-amplified neuroblastoma
Aurora-A prevents transcription-replication conflicts in MYCN-amplified neuroblastoma
MTHFD1 regulates the NADPH redox homeostasis in MYCN-amplified neuroblastoma
Genomic profile of MYCN non-amplified neuroblastoma and potential for immunotherapeutic strategies in neuroblastoma
Inhibitors of ribosome biogenesis repress the growth of MYCN-amplified neuroblastoma
LRP8‐mediated selenocysteine uptake is a targetable vulnerability in MYCN‐amplified neuroblastoma
Impact of extracellular matrix stiffness on genomic heterogeneity in MYCN-amplified neuroblastoma cell line
Age related gene DST represents an independent prognostic factor for MYCN non-amplified neuroblastoma
The long non-coding RNA MYCNOS-01 regulates MYCN protein levels and affects growth of MYCN-amplified rhabdomyosarcoma and neuroblastoma cells
Transcription factor activating protein 4 is synthetically lethal and a master regulator of MYCN-amplified neuroblastoma
Inhibition of autophagy potentiates the efficacy of Gli inhibitor GANT-61 in MYCN-amplified neuroblastoma cells